ArticleCureus2025
Abnormal Biochemical Parameters of Macro- and Microvascular Complications in Diabetic Patients at the Bafoussam Regional Hospital of the West Region, Cameroon.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Diabetes is a metabolic disease characterized by chronic hyperglycemia resulting from a defect in insulin secretion and/or action. It is a global health problem. When left uncontrolled over the long term, hyperglycemia can damage many body's organs, leading to disabling and potentially fatal complications such as cardiovascular disease (CVD), nerve damage (neuropathy), kidney damage (nephropathy), and eye damage, inducing retinopathy, visual loss, and even blindness. Understanding the biochemical parameters associated with diabetic complications is important for effective management and treatment. So, in order to gain insight into the incidence of these complications in diabetic patients and contribute to their better follow-up, a study was carried out at the Bafoussam Regional Hospital with the aim of assessing abnormal biochemical parameters of macro- and microvascular complications in diabetic patients. Methodology A descriptive cross-sectional study was conducted from April to June 2023 at the Bafoussam Regional Hospital on 113 patients of all ages. A questionnaire form was submitted to the participants, and the data from this form were analyzed. Blood samples were collected from the elbow region and used to measure biochemical parameters such as glycosylated hemoglobin (HbA1c), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, creatinine, and urea. Results Participants were classified according to their specific characteristics and the circumstances of the discovery of diabetes. Around 70.8% diabetic patients had uncontrolled blood sugar levels revealed by a high glycated hemoglobin. HDL was high in 18.6% of patients, while it was low in 34.5%. Approximately 0.9% of patients had elevated LDL levels, while in 57.5% of patients, it was low. Triglyceride and total cholesterol levels were elevated in 37.2% and 11.5% of patients, respectively. The cardiovascular risk index and creatinine levels were elevated in 6.2% and 23% of patients, respectively. The multiple logistic regression model showed a significant association between glomerular filtration rate and neuropathy and retinopathy, as well as between creatinemia and nephropathy. Conclusion This study shows that poor glycemic control and longer duration of diabetes are associated with significant alterations in several biochemical parameters, which in turn are linked to an increased risk of macrovascular and microvascular complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.